regorafenib

Bayer’s regorafenib kicks off brain cancer platform trial
Pharmaforum
Thu, 06/20/19 - 09:50 am
Bayer
brain cancer
clinical trials
GBM
regorafenib
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
CP Wire
Wed, 11/14/18 - 11:37 am
Bayer
regorafenib
glioblastoma
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Wed, 11/14/18 - 09:36 am
Bayer
regorafenib
glioblastoma
Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment
Bloomberg
Thu, 09/27/12 - 11:26 am
colorectal cancer
Bayer
ONYX Pharmaceuticals
FDA
regorafenib
Priority Review for Bayer/Onyx
Yahoo/Zacks
Sat, 06/30/12 - 12:52 pm
Bayer
ONYX Pharmaceuticals
regorafenib
colorectal cancer
[video] Onyx Pharma CEO on New Cancer Drug
CNBC
Mon, 06/4/12 - 05:57 pm
ONYX Pharmaceuticals
Anthony Coles
Bayer
regorafenib
gastrointestinal cancer
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Yahoo/Fly on the Wall
Tue, 04/3/12 - 10:12 am
ONYX Pharmaceuticals
regorafenib
GIST
Bayer
Bayer Says Drug Held Off Gastrointestinal Tumors in Study
Bloomberg
Tue, 04/3/12 - 08:57 am
gastrointestinal cancer
Bayer
regorafenib
2 High-Flying Biotechs Face a New Hurdle
Motley Fool
Thu, 01/19/12 - 10:57 am
Bayer
ONYX Pharmaceuticals
Aeterna Zentaris
regorafenib
Keryx
Onyx Colon Cancer Drug Juggles Survival Benefit With Serious Side Effects
TheStreet.com
Wed, 01/18/12 - 10:01 am
ONYX Pharmaceuticals
colon cancer
Bayer
regorafenib
Onyx put selling hinges on time decay
Yahoo/optionMONSTER
Thu, 12/29/11 - 12:01 pm
ONYX Pharmaceuticals
regorafenib
Bayer predicts blockbuster success for four of its late-stage drugs
Fierce Biotech
Tue, 12/20/11 - 11:24 am
Bayer
Xarelto
VEGF Trap-Eye
regorafenib
Alpharadin
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Bayer and new partner Onyx crow over PhIII regorafenib success
Fierce Biotech
Wed, 10/26/11 - 10:30 am
regorafenib
ONYX Pharmaceuticals
Bayer
colon cancer
Onyx Pharmaceuticals extends oncology working relationship with Bayer
Yahoo/AP
Wed, 10/12/11 - 09:25 am
Bayer
ONYX Pharmaceuticals
regorafenib
FDA grants faster review to Bayer's regorafenib
Yahoo/AP
Tue, 05/10/11 - 05:44 pm
Bayer
FDA
regorafenib
gastrointestinal cancer
Bayer Moves Late Stage Candidate
Yahoo/Zacks.com
Mon, 05/17/10 - 04:39 pm
Bayer
ONYX Pharmaceuticals
regorafenib
Bayer/Onyx Cancer Drug: Possible Additional Indication Looks Promising
Seeking Alpha
Sun, 09/27/09 - 11:03 am
Bayer
ONYX Pharmaceuticals
regorafenib

Pages